Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.500
+0.080 (1.81%)
At close: Oct 8, 2025, 4:00 PM EDT
4.500
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $254.38 million as of October 8, 2025. Its market cap has decreased by -50.67% in one year.
Market Cap
254.38M
Enterprise Value
80.55M
1-Year Change
-50.67%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $254.38M, a decrease of -55.01%. That is a compound annual growth rate of -14.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 254.38M | -3.05% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
| Oct 23, 2020 | 565.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |